152 related articles for article (PubMed ID: 36268549)
1. The Role of Ultrasound in Evaluating the Effect of Urate-lowering Drugs in Gout Patients.
El-Mallah R; Ibrahim RA; El Attar EA
Curr Rheumatol Rev; 2022; 18(4):338-345. PubMed ID: 36268549
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound in gout: a useful tool for following urate-lowering therapy.
Ottaviani S; Gill G; Aubrun A; Palazzo E; Meyer O; Dieudé P
Joint Bone Spine; 2015 Jan; 82(1):42-4. PubMed ID: 25543275
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study.
Ebstein E; Forien M; Norkuviene E; Richette P; Mouterde G; Daien C; Ea HK; Brière C; Lioté F; Petraitis M; Bardin T; Ora J; Dieudé P; Ottaviani S
Rheumatology (Oxford); 2019 Mar; 58(3):410-417. PubMed ID: 30285127
[TBL] [Abstract][Full Text] [Related]
4. An exploratory ultrasound study of early gout.
Ottaviani S; Allard A; Bardin T; Richette P
Clin Exp Rheumatol; 2011; 29(5):816-21. PubMed ID: 22011529
[TBL] [Abstract][Full Text] [Related]
5. Musculoskeletal Ultrasound in Monitoring the Efficacy of Gout: A Prospective Study Based on Tophus and Double Contour Sign.
Yuan H; Fan Y; Mou X; Qing Y; Yan X; Tang X; Yue W; Gu P; Yang Q; He Y
Balkan Med J; 2023 Mar; 40(2):104-110. PubMed ID: 36715053
[TBL] [Abstract][Full Text] [Related]
6. Temporal evolution of urate crystal deposition over articular cartilage after successful urate-lowering therapy in patients with gout: An ultrasonographic perspective.
Das S; Goswami RP; Ghosh A; Ghosh P; Lahiri D; Basu K
Mod Rheumatol; 2017 May; 27(3):518-523. PubMed ID: 27492663
[TBL] [Abstract][Full Text] [Related]
7. Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study.
Cipolletta E; Di Battista J; Di Carlo M; Di Matteo A; Salaffi F; Grassi W; Filippucci E
Arthritis Res Ther; 2021 Jul; 23(1):185. PubMed ID: 34243813
[TBL] [Abstract][Full Text] [Related]
8. The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy.
Han L; Li R; Dalbeth N; Liu M; Yu Q; Jiang C; Ning C; Liu Z; He Y; Li M; Xue X; Jia F; Jia Z; Sun W; Zhang H; Lu J; Wang C; Li C
Semin Arthritis Rheum; 2024 Aug; 67():152418. PubMed ID: 38422901
[TBL] [Abstract][Full Text] [Related]
9. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.
Pascual E; Sivera F
Ann Rheum Dis; 2007 Aug; 66(8):1056-8. PubMed ID: 17223663
[TBL] [Abstract][Full Text] [Related]
10. Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy.
Christiansen SN; Østergaard M; Slot O; Keen H; Bruyn GAW; D'Agostino MA; Terslev L
RMD Open; 2020 Jan; 6(1):. PubMed ID: 32396518
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound Evaluation of Three Outcome Domains in the Follow-up of Urate-Lowering Therapy in Gout: An Observational Study.
Zhang W; Zhao D; Wu M; Chen W; Jin Z; Zhang H
Ultrasound Med Biol; 2021 Jun; 47(6):1495-1505. PubMed ID: 33785225
[TBL] [Abstract][Full Text] [Related]
12. Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected.
Lamers-Karnebeek FB; Van Riel PL; Jansen TL
Clin Rheumatol; 2014 Apr; 33(4):555-9. PubMed ID: 24510062
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group.
Christiansen SN; Østergaard M; Slot O; Fana V; Terslev L
Rheumatology (Oxford); 2021 Jan; 60(1):239-249. PubMed ID: 32696059
[TBL] [Abstract][Full Text] [Related]
14. The shrinking toe sign in gout.
Bardin T; Nguyen QD; Hieu NL; Tran KM; Dalbeth N; Do MD; Ea HK; Richette P; Resche-Rigon M; Bousson V
Semin Arthritis Rheum; 2022 Apr; 53():151981. PubMed ID: 35183934
[TBL] [Abstract][Full Text] [Related]
15. UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis.
Ebstein E; Forien M; Norkuviene E; Richette P; Mouterde G; Daien C; Ea HK; Brière C; Lioté F; Petraitis M; Bardin T; Ora J; Dieudé P; Ottaviani S
Joint Bone Spine; 2020 Dec; 87(6):647-651. PubMed ID: 32979555
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of ultrasound-detected tophi in patients with gout.
Lu B; Lu Q; Huang B; Li C; Zheng F; Wang P
Clin Rheumatol; 2020 Jun; 39(6):1953-1960. PubMed ID: 32062769
[TBL] [Abstract][Full Text] [Related]
17. Retrospective longitudinal assessment of ultrasound gout lesions using the OMERACT semi-quantitative scoring system.
Christiansen SN; Østergaard M; Slot O; Fana V; Terslev L
Rheumatology (Oxford); 2022 Nov; 61(12):4711-4721. PubMed ID: 35298610
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved.
Thiele RG; Schlesinger N
Rheumatol Int; 2010 Feb; 30(4):495-503. PubMed ID: 19543895
[TBL] [Abstract][Full Text] [Related]
19. Polyarticular sonographic assessment of gout: a hospital-based cross-sectional study.
Roddy E; Menon A; Hall A; Datta P; Packham J
Joint Bone Spine; 2013 May; 80(3):295-300. PubMed ID: 23142256
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study.
Pascart T; Grandjean A; Norberciak L; Ducoulombier V; Motte M; Luraschi H; Vandecandelaere M; Godart C; Houvenagel E; Namane N; Budzik JF
Arthritis Res Ther; 2017 Jul; 19(1):171. PubMed ID: 28732526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
